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Cellular reprogramming through manipulation of
defined factors holds great promise for large-scale
production of cell types needed for use in therapy
and for revealing principles of gene regulation.
However, most reprogramming systems are ineffi-
cient, converting only a fraction of cells to the
desired state. Here, we analyze MYOD-mediated
reprogramming of human fibroblasts to myotubes,
a well-characterized model system for direct con-
version by defined factors, at pseudotemporal
resolution using single-cell RNA-seq. To expose
barriers to efficient conversion, we introduce a
novel analytic technique, trajectory alignment,
which enables quantitative comparison of gene
expression kinetics across two biological pro-
cesses. Reprogrammed cells navigate a trajectory
with branch points that correspond to two alterna-
tive decision points, with cells that select incorrect
branches terminating at aberrant or incomplete re-
programming outcomes. Analysis of these branch
points revealed insulin and BMP signaling as
crucial molecular determinants of reprogramming.
Single-cell trajectory alignment enables rigorous
quantitative comparisons between biological tra-
jectories found in diverse processes in develop-
ment, reprogramming, and other contexts.258 Cell Systems 7, 258–268, September 26, 2018 ª 2018 The Autho
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During development, cells undergo drastic shifts in gene expres-
sion and epigenetic configuration as they pass from progenitor
or stem cell states to their differentiated states in the adult organ-
ism. Nevertheless, developmental decisions can be ‘‘unmade’’
by ectopic expression of a small number of regulatory genes,
as first shown by Davis et al., who converted murine fibroblasts
to myotube-like cells by overexpressing MyoD, a key myogenic
transcription factor (Davis et al., 1987). Numerous other reprog-
ramming factors have since been discovered, most famously
including four factors that reprogram many different cell types
into induced pluripotent stem cells (iPSCs) (Takahashi and Ya-
manaka, 2006). Following the discovery of MyoD-mediated
transdifferentiation in fibroblasts, Weintraub et al. explored
MyoD’s ability to convert a diverse set of starting cell types to
myotubes (Weintraub et al., 1989). Interestingly, the ectopic
expression of MyoD induced the expression of muscle-specific
structural proteins without altering cell-specific functions. These
studies, concomitant with contemporary heterokaryon experi-
ments (Blau et al., 1983), indicated that neither intracellular
transcription factors nor ectopically transduced MyoD were suf-
ficient for complete reprogramming to the myogenic cell fate.
Despite the following decades of research on cellular conver-
sions, including extensive studies of myogenic reprogramming,
the molecular determinants that impede or mediate reprogram-
ming remain poorly characterized.
Reprogramming can generate dramatically heterogeneous
cell populations, with cells reaching drastically different molecu-
lar outcomes. Single-cell genomics assays provide a means ofrs. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
identifying the different outcomes and could reveal mechanisms
that drive a cell to a particular one. For example, Truetlein et al.
demonstrated through a single-cell transcriptome analysis that
the overexpression of Ascl1, Brn2, and Myt1l generates both
induced neurons and an alternative myocyte-like cell fate (Treut-
lein et al., 2016). However, synthesizing measurements from
these diverse outcomes into a useful picture of the molecular
mechanisms that determine cell fate remains extremely chal-
lenging. Recently, we developed an algorithm that can automat-
ically reconstruct the sequence of expression changes executed
by a cell undergoing differentiation or reprogramming from sin-
gle-cell RNA sequencing (RNA-seq) data. Our algorithm, called
Monocle, introduced the notion of ‘‘pseudotime,’’ which mea-
sures each cell’s progress through a biological process without
the need for a priori knowledge of genes that define progression
(Trapnell et al., 2014). Moreover, Monocle can pinpoint branches
that lead a cell to alternative outcomes, which can reveal the
genes that direct a cell to its ultimate fate. Monocle’s unsuper-
vised learning algorithm enables the discovery of key steps,
roadblocks, and intermediate cellular states on the path to
differentiation.
More recently, we released Monocle 2, which deploys a new
algorithm framework called ‘‘reversed graph embedding’’ that
dramatically improves the accuracy, scalability, and robustness
of Monocle’s trajectory inference (Qiu et al., 2017a, 2017b). In
particular, Monocle 2 was far better at identifying branch points
that correspond to fate decisions made during cell differentia-
tion. Despite the improvements in Monocle 2, the toolkit is still
largely focused on the analysis of a single biological process.
However, many experiments call for the comparison of two
developmental processes. For example, one may wish to
compare the impact of a particular mutation on the development
of a given cell type relative to wild-type cells. Comparing two
pseudotime trajectories is not straightforward because there is
no universal ‘‘unit’’ of pseudotime. A new algorithm is needed
to match up the most similar segments of each trajectory so
that any differences that remain between them can be identified.
Here, wedevelop a novel approach for aligning two pseudotime
trajectories and use it to compare human fibroblasts undergoing
MYOD-mediated myogenic reprogramming to normal muscle
cell development. Through an unsupervised single-cell RNA-seq
analysis, we reveal that the trajectory includes branch points cor-
responding to key ‘‘checkpoints’’ in the process. Cells that travel
down the correct branch progress, while those that travel down
the alternatives fail to convert to myotubes. We show that the
myogenic conversion trajectory does contain a path that is similar
to normalmyoblast differentiation but thatmany cells diverge from
this path toward unproductive reprogramming outcomes.
RESULTS
Pseudotemporal Analysis of MYOD Overexpression
Reveals Multiple Reprogramming Outcomes
We sought to compare the reprogramming activation of the skel-
etal muscle genes in non-muscle cells to their developmentally
regulated onset in normal myoblasts. Previously, we analyzed
primary human skeletal muscle myoblast (HSMM) differentiation
using single-cell RNA-seq by culturing HSMMs to optimal
confluence and then withdrawing mitogens from the growth me-dium (GM) (Trapnell et al., 2014). Within 24 hr of the switch,
HSMMs had exited the cell cycle, aligned with one another,
and by 72 hr in differentiation (DM) had formed myosin heavy-
chain (MHC)-positive myotubes. Monocle showed that HSMM
cells follow a largely linear trajectory, albeit with a single small
branch corresponding to non-differentiating myoblasts (i.e.,
‘‘reserve cells’’) (Qiu et al., 2017a, 2017b). As cells followed
this trajectory, they downregulatedmarkers of the active prolifer-
ation (e.g., CCNB2) and then activated transcriptional regulators
of the skeletal muscle program (e.g.,MYOG), followed by genes
associated with contractile myotubes (MYH3, DMD, ENO3, and
others). To compare myoblast differentiation to myogenic re-
programming, we needed to engineer a fibroblast cell line in
which the myoblast expression program could be induced in a
tightly controlled manner.
To analyze myogenic reprogramming at single-cell resolution,
we first derived a doxycycline-inducible MYOD fibroblast line
(hFib-MyoD), enabling us to synchronize the onset of MYOD
expression. The hFib-MyoD line also harbors a constitutively ex-
pressed human telomerase gene to alleviate passage-dependent
stress, which we previously showed drastically improves unifor-
mity and synchrony of induced pluripotency across cells (Cac-
chiarelli et al., 2015). 72 hr of MYOD transgene expression was
sufficient to produce conversion of fibroblasts to MHC-positive
cells. However, as reported by previous studies (Salvatori et al.,
1995), myogenic reprogramming of human fibroblasts is a very
inefficient process. Only a small proportion of cells are success-
fully reprogrammed, and the result is small,mononucleated,myo-
cyte-like cells (Figures 1A and 1B) rather than long,multinucleated
myotubes as generatedbyHSMM. The number of reprogrammed
cells did not increase with longer time courses (not shown).
To investigate the molecular basis driving HSMM and hFib-
MyoD through the process of myogenic identity, we sampled
single cells every 24 hr post myogenic induction and performed
deep, single-cell, full-length RNA-seq using the FluidigmC1 plat-
form. We recovered a total of 466 high-quality libraries from two
independent reprogramming time series experiments. Although
some markers of myotube formation, such as ENO3, were
induced by MYOD, others including DMD and MYOG showed
expression patterns inconsistent with HSMM (Figure 1C). Few
hFib-MyoD cells expressed MYOG even at 72 hr, which is
required for the upregulation of many genes needed for terminal
differentiation and contraction, including DMD (Bentzinger et al.,
2012). CDK1 and other genes associated with active prolifera-
tion, which were rapidly downregulated in HSMM within 24 hr
following the switch to the differentiation medium, were more
gradually lost, with some cells still expressing them even at
72 hr. The delayed cell-cycle exit may explain why hFib-MyoD
wells contained greater than 3-fold cells than HSMM wells
despite being seeded at comparable initial density (Figure 1B).
Comparing average expression levels in cells collected at each
time point revealed that few of the 653 genes that were signifi-
cantly differentially expressed as a function of time in myoblasts
were regulated to the same extent in hFib-MyoD (Figure 1D).
Single-Cell Trajectory Branch Points Correspond to
Reprogramming Barriers
We next sought to identify the subset of hFib-MyoD cells that
reached a muscle-like expression program and define theCell Systems 7, 258–268, September 26, 2018 259
Figure 1. hFib-MyoD Is a Human Fibroblast
Line that Converts to Myotube-like Cells
upon Doxycycline Induction
(A) Immunostaining of hFib-MyoD and HSMM
with muscle-specific anti-myosin-heavy chain
(MHC) antibodies 72 hr post induction of MYOD-
mediated reprogramming with doxycycline (dox)
or myoblast differentiation via serum switch,
respectively. Scale bar represents 100 mm.
(B) Counts of MHC+ cells, size of MHC+ cells in
pixels, and total nuclei as measured by automated
image processing scripts (see STAR Methods).
Error bars indicate SD across replicates.
(C) Fraction of cells in which mRNAs for selected
muscle markers were detected via full-length sin-
gle-cell RNA-seq.
(D) Fold changes in average expression level of
genes significantly differentially expressed (FDR <
5%) between 0 and 72 hr in differentiating myo-
blasts compared to their corresponding changes
in hFib-MyoD. The blue line indicates a linear
regression, while the red line illustrates perfect
concordance.
(E) The single-cell trajectory reconstructed by
Monocle 2 for hFib-MyoD cells undergoing
myogenic reprogramming. Cells start at the root
and progress to one of three alternative re-
programming outcomes, denoted by F1, F2, and
F3. To reach these fates, cells must pass through
branch point B1. Cells that do not proceed to F1
must then choose between F2 or F3 at branch
point B2.stepwise changes in gene expression that lead to conversion
failure. Since both differentiation and reprogramming are char-
acterized by high levels of asynchrony, obscuring the
sequence of expression changes in such processes, we
applied a recently improved version of Monocle (Qiu et al.,
2017a) to hFib-MyoD. Monocle 2 reconstructed a trajectory
capturing the progression of single cells through myogenic
reprogramming (Figure 1E), which contained three termini
(denoted ‘‘F1,’’ ‘‘F2,’’ and ‘‘F3’’) corresponding to three distinct
reprogramming outcomes. Cells from two independent biolog-
ical replicates were found at each of the three outcomes (Fig-
ure S1). To reach these outcomes, cells passed through at
least one of two branch points (denoted ‘‘B1’’ and ‘‘B2’’). The
trajectory’s root was populated largely by cells collected at
the beginning of the experiment, while the three termini of
the tree were populated by cells collected following the switch
to doxycycline-containing media.
We next assessed the expression of genes regulated in
myoblast differentiation in cells at the three different outcomes260 Cell Systems 7, 258–268, September 26, 2018of the hFib-MyoD trajectory. The cells at
outcome F1 showed expression of genes
upregulated early in myoblast differentia-
tion, such as ENO3, but maintained
strong expression of genes needed for
active proliferation such as CDK1. (Fig-
ure 2A) We next examined the pseudo-
temporal kinetics of CDK1, ENO3, and
TNNT2 as cells traveled from the root
through branch point B1 and then eitherto outcome F1 or toward a second branch point B2. While
ENO3 and TNNT2 were upregulated to a similar extent on both
paths, CDK1 levels dropped markedly in cells traveling to the
branch B2 but remained high in cells traveling to F1 (Figure 2B).
A global differential analysis comparing the two paths away
from branch point B1 revealed 173 genes with branch-dependent
expression (false discovery rate [FDR] < 1%), most of whichwere
associated with the cell cycle. (Figure 2C; Table S1). We exam-
ined our previously collected HSMM data and found that in
contrast to hFib-MyoD, key genes that mark proliferating cells
(CCNB2 and CDK1) are almost never co-expressed with early
myogenic markers (e.g., ENO3 and TNNT2) in these cells
(Figure 3). Although hFib-MyoD cells at F1 co-expressed
numerous markers of both proliferation and the early myoblast
differentiation program, they expressed few markers of mature,
contractile myotubes. In normal differentiating myoblasts, prolif-
eration genes are downregulated prior to the onset of skeletal
muscle genes, indicating that F1 may be an aberrant cellular
state within the myogenic reprogramming process.
Figure 2. Single-Cell Trajectory Analysis with Monocle 2 Identifies Three MYOD-Mediated Myogenic Reprogramming Outcomes in
hFib-MyoD
(A) Cells along the trajectory divided into four groupings based on expression of CDK1 and ENO3. Contour plots indicate two-dimensional Gaussian kernel
density estimates. Cells are colored according to the facet in which they reside. hFib-MyoD cells were ordered using genes that were both used to order the
HSMM cells (as described in Qiu et al., 2017a, 2017b) and also detectably expressed in hFib-MyoD cells.
(B) Pseudotime kinetics of CDK1, ENO3, and TNNT2 from the root of the trajectory to outcome F1 (solid line) and the cells up to branch point B2. Cells are colored
by their expression of CDK1 and/or ENO3, as in (A).
(C) All genes expressed in a branch B1-dependent manner. Each row indicates the standardized (row-centered) kinetic curves of a gene. The center of the
heatmap shows the kinetic curve value at the root of the trajectory. Proceeding from the center to the left of the heatmap follows the kinetic curve from the root
along the trajectory to outcome F1. Proceeding to the right yields the curve from the root to B2. The curve values for each gene are normalized to Z scores to
facilitate comparison of genes kinetics.We next analyzed the path that led away from branch point B1
to a second branch point B2, which in turn gave rise to outcomes
F2 and F3 (Figure 4A). The cells at F2 expressed MYOG, lacked
markers of active proliferation, and showed upregulation of
numerous genes needed for muscle contraction (Figures 4B
and S2). Branch-dependent expression analysis at B2 showed
significant changes in 277 genes (FDR < 10%), including a
coherent cluster that included TNNI1, TNNT3, MYL4, and other
notable proteins involved in myotube contraction (Table S2) (Fig-
ure 4C). In contrast, cells at F3 lacked expression ofMYOG, cell-
cycle genes, and most of those needed for muscle contraction.
We therefore concluded that B1 is a decision point correspond-
ing to whether a cell will exit the cell cycle, while B2 is a decision
point governing whether, having exited the cell cycle, it will go on
to activate themyogenic program. Based on our differential anal-
ysis, we termed the three hFib-MyoD reprogramming outcomes
F1, F2, and F3 as ‘‘cell-cycle exit failure,’’ ‘‘partial reprogram-
ming,’’ and ‘‘reprogramming failure,’’ respectively.
Aligning Single-Cell Trajectories via Dynamic Time
Warping
Having identified the core trajectory from the fibroblast state to a
partially reprogrammed state, we next sought to quantify the dif-
ferences between this program of gene expression changes and
the one associated with normal myoblast differentiation. In prin-
ciple, combining the HSMM and hFib-MyoD cells and building a
joint trajectory could show how the two cell types converge to-
ward a muscle expression program, with cells of both types
co-occupying positions of the graph corresponding to success-
ful activation of the myogenic program. However, Monocle re-
constructed a fully linear trajectory with no intermixing of cellsat similar stages (Figure S3A). This is likely because despite
having some genes regulated in a common direction such as
MEF2C and ENO3, many other genes differ between the cell
types, and these differences persist throughout reprogramming
and differentiation.
We therefore developed a new algorithmic approach for
comparing the HSMM and hFib-MyoD trajectories. A successful
comparison between two trajectories should reveal to the user
which cells from each are in similar gene expression states and
which cells are in states unique to each biological process under
study. Because the two single-cell trajectories were learned from
each dataset independently, their pseudotime scales are not
directly comparable; there is no universal ‘‘unit’’ of pseudotime.
Simply combining two different cell types into a single Monocle
analysis does not reveal any similarities between their trajec-
tories. We thus devised a ‘‘manifold alignment’’ algorithm (Ham
et al., 2003) based on dynamic time warping (DTW) (Vintsyuk,
1972), which matches highly similar points on the two trajec-
tories and creates a mapping between the HSMM and hFib-
MyoD pseudotime scales. (Figure 5; Data S1). DTW operates
analogously to sequence alignment in that it reports how
one trajectory must be deformed (i.e., dilated in some regions
and contracted in others) in order to closely match the other tra-
jectory. It matches up the most similar regions of the trajectories
so their differences are apparent. In a complementary study pub-
lished while this manuscript was in revision, Welch et al. devised
an algorithm, MATCHER, that can align two linear pseudotem-
poral trajectories that have been reconstructed from different
measurement types (e.g., gene expression and DNA methyl-
ation) (Welch et al., 2017). Like MATCHER, our algorithm
assumes the cells proceed through linear biological processCell Systems 7, 258–268, September 26, 2018 261
Figure 3. Fraction of Cells Co-expressing Selected Markers of Proliferation and Myoblast Differentiation, Shown for Both HSMM and hFib-
MyoD Cellsmonotonically and that progression through each biological pro-
cess leads tomeasurable changes in gene expression. However,
where MATCHER assumes that both experiments examine the
same cell type, we aim to align cells of different types (e.g., fibro-
blasts and myoblasts) that proceed through similar processes.
Our algorithm aligned the HSMM and hFib-MyoD trajectories
along a ‘‘warping path’’: a sequence of matchings between an
HSMM and an hFib-MyoD cell such that the most transcriptomi-
cally similar cells (and thus points in HSMM and hFib-MyoD
pseudotimes) are linked (Figure 6A). Just as ‘‘edit distance’’ in
DNA sequence alignment measures the number of base trans-
versions, insertions, and deletions needed to transform a
sequence into one aligned to it, the length of this warping path
quantifies the total amount of transcriptome ‘‘distortion’’ needed
to transform one gene expression trajectory into another.
Randomly permuting the order of the HSMM and hFib-MyoD
cells and then aligning these shuffled trajectories produced far
longer warping paths than the correctly ordered trajectories (Fig-
ure 6B). Because warping path lengths of shuffled trajectories
appeared to be normally distributed (p = 0.68, Shapiro-Wilk
test), we were able to determine that the warping path between
the unshuffled trajectories was significantly shorter (p < 1016, t
test), suggesting that DTW fixed on genuine biological signal to
match up the pseudotime scales.
Because our method assumes the two input trajectories are
correctly inferred, we set out to explore the robustness of trajec-
tory inference with Monocle 2 and its impact on downstream
trajectory alignment. Monocle 2 produces trajectories that are
robust to many choices of its parameter values, but there are
several that can dramatically impact the topology of the trajec-262 Cell Systems 7, 258–268, September 26, 2018tory. The set of genes used for ordering, which defines the
high-dimensional space in which the original data reside prior
to embedding, can have a major impact on the interpretation
of the biological process under scrutiny (Qiu et al., 2017a,
2017b). When we used all 441 genes that varied significantly
over time in the HSMM experiment instead of just the top 100,
Monocle 2 produced a nearly identical HSMM trajectory, but
the hFib-MyoD trajectory failed to capture the split between
partially reprogrammed and unreprogrammed cells (Figure S3B).
Changing one of Monocle 2’s key regularization parameters had
a similar effect. Ordering both sets of cells by genes that undergo
time-dependent changes in expression in hFib-MyoD rather than
HSMM led to a loss in the ‘‘failure to exit’’ branch in the hFib-
MyoD trajectory and a failure to place some MYOG+ cells on
the partially reprogrammed branch (Figure S3C).
The alternative trajectories produced by changing the ordering
genes or regularization parameters have some topological fea-
tures in commonwith the one shown in Figure 2A, but each failed
to segregate the cells of the ‘‘reprogramming failure’’ and ‘‘partial
reprogramming’’ outcomes onto distinct paths. Because there is
typically no experimentally derived ‘‘ground truth’’ ordering for a
set of cells, benchmarking a trajectory’s accuracy typically re-
quires checking whether it can be reconciled with time series
immunofluorescence or other kinetic measurements of the sys-
tem. At the 72-hr post-serum switch, both cultures contain nuclei
in MYH+ cells as well as cells lacking MYH (Figure 1). Therefore,
both trajectories should have at least two outcomes, one with
partially reprogrammed cells (MYH+) and one in which the
myogenic program failed to activate (MYH). These analyses
suggest that although Monocle 2 is somewhat sensitive to
Figure 4. Two of the Outcomes Reached by hFib-MyoD Feature Cell-Cycle Exit Followed by Varying Levels of Activation of the Skeletal Mus-
cle Expression Program
(A) Cells colored by detection of MYOG mRNA.
(B) Kinetic curves for ENO3, MEF2C, and TNNT3 from the root through B2 to outcomes F2 (dashed line) and F3. Cells are colored as in Figure 2A.
(C) Branched kinetic heatmap for all genes dependent on B2, along with selected enriched gene ontology terms in indicated clusters.parameters, the trajectories we have aligned here are consistent
with the independent techniques for assessing myogenic differ-
entiation kinetics.
Aligning Single-Cell Trajectories Identifies Key
Molecular Determinants of Myogenic Reprogramming
Because numerous pathways and transcriptional circuits play a
role in muscle development, we therefore sought to use our
alignment to reveal which of them might contribute to the failure
of hFib-MyoD cells to fully reprogram. The alignment between
HSMM and hFib-MyoD revealed extensive quantitative
differences in expression kinetics between their trajectories,
highlighting several coherent clusters of genes missing in hFib-
MyoD or aberrantly regulated relative to HSMM (Figure 6C).
Most of the cell-cycle markers, such as CDK1, displayed similar
kinetics in both hFib-MyoD and HSMM, indicating that on the
core hFib-MyoD trajectory, the cell-cycle exit proceeds swiftly
following media switch. MEF2C, a crucial co-factor for MYOD
and MYOG in myoblasts, was upregulated with similar timing
but to a lesser extent in hFib-MyoD.MYOG, in contrast, was up-
regulated far later in hFib-MyoD than HSMM, to a lesser extent,
and in a smaller proportion of cells (Figure 6D).
In myoblasts, MEF2C andMYOG both auto-regulate their own
expression (Edmondson et al., 1992; Wang et al., 2001), after
initially being upregulated by MYOD. MYOD activates its targets
by forming a heterodimer with E47, which together recruit p300
to robustly transactivate the late myogenic expression program.
The activity of p300 atMYOD-bound promoters is driven through
Akt-mediated insulin signaling (Serra et al., 2007). Formation of
the MYOD/E47 heterodimer is inhibited by ID family proteins
(Neuhold and Wold, 1993), which sequester E proteins away
from chromatin. In proliferating myoblasts, ID family proteins
are maintained at high levels by an incompletely understood
mechanism that is likely downstream of BMP signaling (Lewisand Prywes, 2013), which acts to allow sufficient myoblast
expansion from satellite cells during regeneration (Sartori et al.,
2013). During differentiation, ID expression drops, enabling
E47 to form heterodimers with MYOD at promoters of key
muscle genes. Expression levels of insulin receptor (INSR) and
the insulin-like growth factor receptors (IGF1R and IGF2R)
were significantly lower in hFib-MyoD. (Figure 6D) IGF2, which
drives myoblast differentiation in an autocrine loop (Florini
et al., 1991), was strongly upregulated in HSMMs but not hFib-
MyoD. Furthermore, ID1 and ID3 were at far higher levels in
hFib-MyoD and were maintained throughout differentiation.
BMP4 was expressed in hFib-MyoD, while HSMMs did not ex-
press BMP family mRNAs at appreciable levels. (Figure 6D) We
thus hypothesized that high levels of BMP and insufficient insulin
signaling were locking hFib-MyoD cells in a negative feedback
loop, preventing their efficient activation of the myotube expres-
sion program.
Cell-Extrinsic Factors Are Required forMYOD-Mediated
Myogenic Reprogramming
To test whether modulating insulin or BMP signaling could
enhance myogenic conversion efficiency, we supplemented
the differentiation medium with recombinant insulin protein, a
chemical inhibitor of the BMP receptor, or both. After 120 hr of
conversion in the presence of insulin, hFib-MyoD showed
marked increases in the number of myotubes (Figure 7A). Myo-
blasts cultured with insulin did not form significantly more
myotubes, but myotube size, the number of nuclei residing in
myotubes, and nuclei per myotube all increased at least 2-fold,
indicating far more efficient fusion. Inhibition of BMP signaling
also significantly increased the number, size, and nuclei count
of hFib-MyoD-derived myotubes. (Figure 7B) The addition of
both insulin and the BMP inhibitor increased myotube number,
size, and nucleation more than adding either alone, suggestingCell Systems 7, 258–268, September 26, 2018 263
Figure 5. Core Trajectories of Myogenic Reprogramming and Differentiation
The core trajectories of hFib-MyoD (left) and HSMM (center) were aligned using dynamic time warping (Giorgino, 2009; Rabiner and Juang, 1993; Vintsyuk, 1972)
(DTW; right), a dynamic-programming time series alignment technique, which matches pseudotime coordinates on the hFib-MyoD trajectory to the most best
matching points in the HSMM trajectory as determined by similarity in global expression.that these pathways act independently to modulate hFib-MyoD
conversion efficiency. Importantly, neither insulin nor the BMP
inhibitor altered the total number of nuclei in the experiment, indi-
cating that variation in myotube efficiency was not due to varia-
tion in cell counts. Together, these results suggest that MYOD is
sufficient to convert human foreskin fibroblasts tomyotubes only
in the presence of appropriate upstream signaling from core
myogenic pathways.
MYOD has been characterized as a ‘‘pioneer’’ transcription
factor because of its sufficiency in remodeling chromatin at inac-
tive regulatory sites in the genome (Zaret and Carroll, 2011).
Recently, a number of studies have shown that genetically or
chemically modulating the activity of chromatin remodeling en-
zymes alters the efficiency, timing, and heterogeneity of reprog-
ramming to the pluripotent state. For example, we showed that
inhibiting the activity of the histone demethylase LSD1, which
removes mono- and di-methyl groups from lysine 4 in the tail
of histone H3 (H3K4m1/2), improves fibroblast-to-iPSC conver-
sion efficiency by 10-fold (Cacchiarelli et al., 2015). Similarly,
incubating hFib-MyoD cells with an LSD1 inhibitor dramatically
increased their conversion tomyotubes in the presence of insulin
(Figure 6D). In contrast, the inhibitor had only a modest effect in
the absence of insulin and no effect on HSMM differentiation.DISCUSSION
The landmark discovery by Takahashi and Yamanaka that devel-
opmental decisions can be reversed with the ectopic expression
of four factors, ultimately converting fibroblasts into pluripotent
cells, raised the prospect of large-scale manufacture of arbitrary
cell types and tissues. (Takahashi and Yamanaka, 2006). During
reprogramming, several key developmental decisions are
observed (Cacchiarelli et al., 2015; Takahashi et al., 2014). How-
ever, for most cell types, we lack effective protocols for differen-
tiating them from pluripotent cells or direct ‘‘reprogramming
cocktails’’ that would generate them from another cell type.
The cocktails that do exist generally only work on one or a hand-
ful of initial cell types, often with poor and variable efficiency
(Vierbuchen and Wernig, 2011) (Xu et al., 2015). Developing
better methods for dissecting the molecular basis for different264 Cell Systems 7, 258–268, September 26, 2018reprogramming cocktails is therefore critical for realizing the
promise of efficient manufacture of therapeutically relevant cells.
MYOD is perhaps the best characterized ectopic reprogram-
ming factor and has been extensively studied as a model
‘‘master regulator’’ of cell fate. Central to its identity is its ability
to single-handedly convert various cell types into muscle. How-
ever, as noted, some cell types, such as HeLa cells (Weintraub
et al., 1989), remain refractory to myogenic conversion for rea-
sons that until recently remained poorly understood. Work by
Forcales et al. showed that HeLa cells can be converted to my-
otubes with MYOD only when BAF60C, a subunit of the BAF
ATP-dependent chromatin remodeling complex (present in
mesodermal lineages), is also expressed along with appropriate
signaling from p38ɑ (Forcales et al., 2012). That is, MYOD’s abil-
ity to reprogram to muscle is dependent upon the presence of
factors needed for ATP-dependent chromatin remodeling.
Our study shows that the extracellular signaling environment
must also be supportive for efficient MYOD-mediated reprog-
ramming of fibroblasts to myotubes. Using pseudotemporal sin-
gle-cell transcriptome analysis to ‘‘debug’’ our reprogramming
system, we identified two molecular barriers to conversion.
The first is the failure to engage a central autocrine positive feed-
back loop driven by insulin signaling, which is supplied by IGF2 in
myoblasts. The second is that hFib-MyoD cells secrete BMP4,
which may activate a negative autocrine loop and impede
myogenic conversion. Supplementing the cellular milieu with in-
sulin and a BMP inhibitor rescued MYOD’s ability to convert
these fibroblasts to myotubes. Although these pathways are
known to play a role inmuscle development and reprogramming,
so do many others (Knight and Kothary, 2011); trajectory align-
ment identified these as the specific barriers in our system that
should be disrupted to ease conversion. Alignment of single-
cell trajectories is thus a powerful technique for isolating the
sequence of productive state transitions leading to effective
cell type conversion.
Dependence on a supportive extracellular signaling environ-
ment might explain variable reprogramming efficiency during
not only myogenic reprogramming but many other reprogram-
ming settings. Furthermore, while the importance of engaging
regulatory feedback loops for reprogramming, differentiation,
and maintenance of the pluripotent and other cellular states is
Figure 6. Alignment of Myogenic Reprogramming and Myoblast Differentiation Trajectories Identifies Insulin and BMP Signaling as Aber-
rantly Regulated in hFib-MyoD
(A) The DTW alignment (cyan curve) follows a dissimilarity-minimizing path through the ‘‘landscape’’ of possible ways to pair up points on the two pseudotime
curves. The contours indicate levels of equal similarity between global expression profiles of typical cells at indicated HSMM and hFib-MyoD pseudotimes.
HSMM and hFib-MyoD cells were aligned to minimize differences in the union of genes used to order the two sets of cells.
(B) The distribution of normalized lengths of the warping path as reported by the DTW package for shuffled trajectories. Shuffling was conducted immediately
prior to computing all pairwise distances between points on the two pseudotime series. The red line indicates the length of the warping path (0.58) of the un-
shuffled data.
(C) Clustered heatmap of genes showing significant differences in aligned kinetic curves (FDR < 10%; likelihood ratio test; see STAR Methods) after
controlling for common pseudotime-dependent differences. Each row shows a different gene. Columns correspond to the log-transformed fold change of
the curve for hFib-MyoD over that of HSMM at each point in the aligned trajectory. These values were further transformed into per-gene Z scores prior to
clustering. Genes are clustered by Ward’s method and tested for enrichment of genes in REACTOME pathways, with selected significantly enriched
pathways shown.
(D) Aligned kinetic curves for the indicated marker genes, all of which show significant differential pseudotime-dependent expression.well appreciated, feedback loops are most frequently discussed
in the context of transcriptional circuits that govern these pro-
cesses. Our work underscores the importance of establishing
(or interrupting) autocrine signaling feedback loops in order to
reach a desired cellular state.
Beyond providing insights into barriers to myogenic reprog-
ramming, our study shows that pseudotemporal single-cell
trajectory alignment is a powerful approach for dissecting bio-
logical processes. Alignment can reveal kinetic differences in
how each gene is regulated in the two processes and could be
useful for understanding not only how reprogramming comparesto normal cell differentiation but also how a dynamic process
proceeds differently under different environmental conditions
or how a mutation alters it. Our alignment algorithm as well as
other recently proposed approaches such as MATCHER make
several assumptions regarding the underlying biological pro-
cesses being compared. If these assumptions are not met, or if
the trajectories provided as input are incorrectly constructed,
the alignment will not yield an accurate picture of how the biolog-
ical process under study is similar or different. It is conceivable
that a future algorithm that jointly learns trajectories for two or
more processes simultaneously along with the mappingCell Systems 7, 258–268, September 26, 2018 265
Figure 7. Adding Insulin, Inhibiting BMP Signaling, and Inhibiting LSD1 Activity Increase Myogenic Conversion Efficiency
(A) Immunostaining of hFib-MyoDwithmuscle-specific anti-myosin-heavy chain (MHC) antibodies 120 hr post induction ofMYOD-mediated reprogramming. Top
inset indicates control cells. Cells in themiddle and bottom insetswere treatedwith insulin or insulin andBMP inhibitor, respectively. Scale bars represent 100 mm.
(B) Counts of MHC+ cells, size of MHC+ cells in pixels, and total nuclei as measured by automated image processing scripts (see STAR Methods). Error bars
indicate SD across replicates.
(C) A model summarizing how the extracellular signaling environment conditions cells for reprogrammability by MYOD. An unsupportive environment that ex-
poses cells to BMP maintains cellular ID family protein levels, which in turn suppress the myogenic program by interfering with the formation of active MYOD-
containing transcription complexes. A supportive environment lacking BMP and containing insulin engages an IGF2-mediated autocrine feedback loop that
amplifies expression of MYOG and potentially its co-factors, leading to efficient induction of the myogenic expression program.between them might be more robust to user-provided parame-
ters. Despite these limitations, trajectory alignment can advance
our understanding of not only how two biological processes266 Cell Systems 7, 258–268, September 26, 2018relate to one another but also how different layers of gene regu-
lation are linked in the same process. Trajectory alignment is
applicable to these and many other settings and should yield
insights into the molecular mechanisms of reprogramming, cell
differentiation, and a wide array of other biological processes.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
MHC/MYH2 eBioscience Cat. 14-6503; CLONE MF20
Chemicals, Peptides, and Recombinant Proteins
Puromycin Dihydrochloride ThermoFisher Scientific Cat. A1113803
Hygromycin B ThermoFisher Scientific Cat. 10687010
Blasticidin S HCl ThermoFisher Scientific Cat. A1113903
FGF-Basic ThermoFisher Scientific Cat. PHG0263
Doxycycline Hyclate Sigma-Aldrich Cat. D9891
Insulin ThermoFisher Scientific Cat. 12585014
LSD1 inhibitor - RN-1 EMD Millipore Cat. 489479
BMP inhibitor - LDN-193189 Stemgent Cat. 04-0074
Critical Commercial Assays
C1 Single-Cell Auto Prep System Fluidigm Cat. 100-5950
Deposited Data
hFib-MyoD Reprogramming Single Cell Transcriptome NCBI Geo DataSets GEO: GSE105211
Experimental Models: Cell Lines
Human Foreskin Fibroblasts (BJ) Stemgent Cat. 08-0027
Human Skeletal Muscle Myoblasts (HSMM) Lonza Cat. CC-2580
Recombinant DNA
pLVX-EF1a-hTERT-IRES-Puro This paper N/A
ViraPower T-Rex Gateway Expression System (MyoD) This paper N/A
Software and Algorithms
Monocle v.2.5.4 N/A N/A
TopHat v.2.1.1 N/A N/A
Cufflinks v.2.2.0 N/A N/A
Human hg19 genome reference N/A N/A
Gencode v17 transcriptome index N/A N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contacts, Cole
Trapnell (coletrap@uw.edu) and Davide Cacchiarelli (d.cacchiarelli@tigem.it).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture and Derivation
HSMM derivation, expansion and differentiation was as previously described (Trapnell et al., 2014). Foreskin Human Fibroblasts
obtained from commercial vendor (Stemgent) were expanded in alpha-mem supplemented with glutamax, 10% FBS and 16ng/ul
of FGF-b (ThermoFisher Scientific). The fibroblasts were then infected with a mixture of lentiviruses encoding hTERT (and Puromycin
resistance gene) (pLVX system from Clontech), Tetracycline Repressor (and Geneticin resistance gene) and TR-controlled
hMyoD (and Blasticidin resistance gene) (ViraPower T-Rex system from ThermoFisher Scientific). All the resistance genes are consti-
tutively expressed and therefore triple selection was performed and maintained using 1ug/ml of Puromycin, 500ug/ml of Geneticin
and 2ug/ml of Blasticidin to generate the hFib-MyoD line.
To perform reprogramming and differentiation experiments HSMMand hFib-MyoD cells were plated in 24-well formats at a density
between 50.000 and 100.000 cells per well. Gelatin was sometime used as a coating agent with no significant difference with respect
to uncoated dishes. Differentiation and reprogramming was induced using a differentiation media containing alpha-mem supple-
mented with glutamax and 2% HS (ThermoFisher Scientific), supplemented with 2ug/ml of doxycycline to enact MYOD expression.Cell Systems 7, 258–268.e1–e3, September 26, 2018 e1
When indicated, Insulin was used at 8ug/ml (ThermoFisher Scientific), BMP inhibitor LDN-193189 was used at 0.1uM (Stemgent),
LSD1 inhibitor RN-1 was used at 1uM (EMD Millipore).
METHOD DETAILS
Imaging-Based Quantification of Myotube Formation
At the indicated time points, cells were fixed, stained, imaged and processed as previously described (Trapnell et al., 2014). Briefly,
we fixed the cells in 4% PFA, stained for and MHC antibody at a 1:500 dilution (ebioscience) and whole-well imaged using a Celigo
Cytometer (Nexcelom). The imaging/counting script is available upon request.
SINGLE-CELL TRANSCRIPTOME SEQUENCING
At the indicated time points, cells were harvested by gentle dissociation using TrypLE (ThermoFisher Scientific) and processed for
full-length transcriptome sequencing using the Fluidigm C1 Single Cell or bulk mRNA sequencing as previously described (Trapnell
et al., 2014). Cells were loaded onto microfluidic chips optimized for capturing cells in 10-17 micron in diameter. Cells were sus-
pended at a concentration of250 cells/ml to maximize the number of single cells captured andminimize the occurrence of doublets.
In some instances, cells were reloaded if the majority of capture sites were not occupied on the first attempt. As in Trapnell et al.
(2014), captured cells were scored by manual on-chip microscopic inspection to determine if they were singletons and free of other
debris. Gene expression profiles for each cell were computed using TopHat (v 2.1.1) and Cufflinks (2.2.0) software packages, which
were provided with the hg19 genomic reference and GENCODE v17 transcriptome index.
Single-Cell Trajectory Reconstruction
Single-cell pseudotime trajectories were constructed with Monocle version 2.5.4. Monocle 2 is a dramatically more powerful method
than our previous software. Briefly, it uses Reversed Graph Embedding, a machine learning technique that given high dimensional
data, constructs a principal graph approximating amanifold in a low-dimensional space. Single cells are projected onto thismanifold,
which orders them into a trajectory and identifies any branch points corresponding to cell fate decisions. (Qiu et al., 2017a)
Myoblasts were ordered similarly to the procedure we described in Qiu et al. Briefly, expression levels were first converted into
relative mRNA counts using Census (Qiu et al., 2017b). Cells with more than 1e6 Census RNAs were filtered as cells that failed con-
version. From this set, cells with +/- 2 standard deviationsmore or less than themean total Census RNAswere also excluded as either
low-complexity libraries or suspected doublets not caught by visual inspection. The HSMM culture contains a mixture of myoblasts
and contaminating interstitial fibroblasts, so we informatically classified each cell on the basis of semi-supervised clustering.
We then collected a set of ordering genes that defined myoblast differentiation by testing each gene for differential expression be-
tween the four time points in the experiment. Selection of ordering genes is crucial for trajectory inference (Qiu et al., 2017a, 2017b).
We depart from our previously published protocol for ordering the HSMM data to enrich the ordering genes for those that are key
markers ofmuscle differentiation by selet the top 100most significant genes for downstreamordering analysis. These genes included
MYOG, MEF2C, and other muscle markers, but excluded a number of genes that are highly expressed but less specifically associ-
ated with muscle development (e.g. those involved in ribosome biogenesis). Expression profiles were reduced to 2 dimensions using
the DDRTree algorithm (Mao et al) included with Monocle 2, via the reduceDimension(), with ncenter=50 and param.gamma=100.
These two parameters control how aggressively Monocle 2 regularizes away small branches in the trajectory. They were manually
optimized to produce orderings of HSMM and hFib-MyoD that were most consistent with each other and with other data in the study
(e.g. immunofluorescence).
hFib-MyoD cells were filtered for quality and ordered similarly to the myoblasts, though we made no attempts to split the popu-
lation, as there is no contamination of other cells types in the culture. hFib-MyoD cells were ordered on the basis of the same genes
used to order the myoblasts, excluding those genes not detected in at least 5 cells. As there are more hFib-MyoD cells than myo-
blasts, parameters to reduceDimension(), were adjusted (ncenter=100 and param.gamma=100).
Trajectory Alignment
We use Dynamic Time Warping (DTW) to compute the optimal alignment between the HSMM and hFib-MyoD trajectories. We refer
readers to (Giorgino, 2009; Rabiner and Juang, 1993) for a detailed discussion, and summarize the algorithm below. Briefly, DTW,
aims to compare two longitudinal data series to one another by locally stretching or compressing them and make them resemble
each other while preserving their order. The algorithm takes as input a distance matrix d that captures the dissimilarity between
each pair of elements of a vector X and Y. Because DTW takes as input the matrix d, rather than directly examining X and Y, they
can be vectors of multivariate observations, categorical values, or some mix of these, provided that the user defines a suitable dis-
tance function. DTW computes a ‘‘warping curve’’
fðkÞ; k = 1;.;T:fðkÞ= fxðkÞ;fyðkÞ

;e2 Cell Systems 7, 258–268.e1–e3, September 26, 2018
where the warping function fx maps the time indices of X to that of Y and and fy maps Y indices to that of X. DTW then can compute











The per-step weightmfðkÞ and the normalization constantMf aim to make the accumulated distortions along different alignment
paths comparable. These weights are determined according to the user’s ‘‘step pattern,’’ several of which are made available by the
DTW implementation. DTW then finds optimal alignment f (subject to additional constraints to preserve the ordering of the data
points) via dynamic programming.
To align the hFib-MyoD andHSMM trajectories, we first selected cells along the ‘‘productive’’ paths from the root of each trajectory
to outcomes F2 and F1, respectively. Next we generated smoothed expression curves (using Monocle 2’s genSmoothCurves() func-
tion) for the union of the ordering genes used to create each cell type’s trajectory. Genes for which curves could not be generated due
to numerical instabilities in either cell type were excluded. These curves were then standardized independently, scaling each to have
a mean of zero and a standard deviation of 1. The curves were collected into a pair of matrices, H andM for the myoblasts and the
hFib-MyoD cells, respectively, with one row per gene and one column for each of the 100 points on each gene’s smoothed curve. The
pairwise dissimilarities between each of the 100 pseudo time points inM and the 100 points in F were then computed as d (i, j) = 1
cor (Hi, Mj). These pairwise distances capture the global similarity between myoblasts and hFib-MyoD cells at each pair of points on
their trajectories. DTWallows the user to specify the cost of skipping points in one time series or another, analogously to howdynamic
programming for sequence alignment imposes different costs for insertions, deletions, and mismatches. Here, we provide DTWwith
a ‘‘step pattern’’ specified by rabinerJuangStepPattern(3, "d"). To project the two trajectories onto a common pseudotime scale, we
use the warp() function of the dtw package.
Differential Expression Analysis
We tested for differential gene expression as a function of pseudotime (j) asy
::
previously described (Qiu et al., 2017b; Trapnell et al.,
2014): We fit the following model:
lnðAiÞ= b0 + bjj

;
whereAi is themean of a negative-binomial valued random variable of theCensus-normalized transcript count for gene i, and the tilde
above j indicates that these predictors are smoothed with natural splines during fitting. This model was compared to the reduced
model containing only an intercept coefficient
lnðAiÞ= b0
by likelihood ratio test. Genes with an Benjamini-Hochberg adjusted p-value of less than 0.05 were determined to be dynamic across
pseudotime.
When testing for differences between HSMM and hFib-MyoD, we used a modified model to identify genes that were regulated in a
pseudotime-dependent manner differently between the two cell types:








where C is an indicator variable encoding the cell type, and j

HSMM is the pseudotime scale of HSMM, onto which the hFib-MyoD
cells were projected by DTW. This full model was compared to
lnðAiÞ= b0 + bjHSMMj

HSMM:
By likelihood ratio test to identify genes with cell-type dependent differences in expression, while controlling for differences in
expression due to pseudotime that might be common to the two.
DATA AND SOFTWARE AVAILABILITY
Data for this study have been deposited with the Gene Expression Omnibus at GEO: GSE105211.Cell Systems 7, 258–268.e1–e3, September 26, 2018 e3
